Qiling Gou
Overview
Explore the profile of Qiling Gou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
You H, Gou Q, Dong M, Chang F, Xiu J
Biochem Biophys Res Commun
. 2024 Sep;
734:150589.
PMID: 39245028
Background: Heart failure with preserved ejection fraction (HFpEF) is a challenging condition to treat with myocardial fibrosis being a pivotal pathological component. Previous studies have suggested a role for inducible...
2.
Qi J, Dong M, Gou Q, Zhu H
Cell Biochem Biophys
. 2024 Sep;
82(4):3235-3249.
PMID: 39235508
Metformin has a long history of clinical application and has been shown to have outstanding ability in lowering glucose. Recent advances have further revealed its broad modulatory ability beyond glucose-lowering,...
3.
Gou Q, Zhao Q, Dong M, Liang L, You H
Front Endocrinol (Lausanne)
. 2023 Dec;
14:1296547.
PMID: 38089628
Background: Heart failure with preserved ejection fraction (HFpEF) is associated with changes in cardiac metabolism that affect energy supply in the heart. However, there is limited research on energy metabolism-related...
4.
Gou Q, Liang L, Liu D, Jia J, Dong M, Chen H, et al.
Am J Emerg Med
. 2023 Jul;
71:139-143.
PMID: 37392513
Background: Non-ST-segment elevation myocardial infarction (NSTEMI) is a common form of acute myocardial infarction and rapid and accurate diagnosis is crucial for timely treatment. Current guidelines recommend using high-sensitivity cardiac...
5.
Qi J, Han W, Zhong N, Gou Q, Sun C
Funct Integr Genomics
. 2022 Dec;
23(1):16.
PMID: 36562844
Coronary heart disease is a cardiovascular disease with high morbidity and mortality. Although great progress has been made in treatment, the prognosis is still very poor. Therefore, this project aims...
6.
You H, Zhao Q, Gou Q, Dong M
Ann Transl Med
. 2022 Dec;
10(21):1164.
PMID: 36467363
Background: Accumulating evidence indicates the inflammatory state of rheumatoid arthritis (RA) predisposes to the acceleration of atherosclerosis (AS). Nevertheless, the potential mechanisms of accelerating AS in RA have not been...
7.
Rong X, Zhu Y, Wen B, Liu K, Li X, Gou Q, et al.
Front Cardiovasc Med
. 2022 Dec;
9:973129.
PMID: 36451919
Aim Of The Review: To assess the risk of hypovolemia for sodium-glucose cotransporter-2 (SGLT2) inhibitors treatment. Method: A systematic literature retrieval was performed in PubMed, Embase, Cochrane Central Register of...
8.
Hu X, Zhang X, Zhang Z, Li X, Gou Q, Ye R, et al.
BMC Cardiovasc Disord
. 2022 Aug;
22(1):357.
PMID: 35931987
Background: There is limited evidence regarding the relationship between lipid parameters and vascular mechanical characteristics in the normotensive population without diabetes mellitus. The aim of this study was to identify...
9.
Yang X, Yuan Y, Gou Q, Ye R, Li X, Li J, et al.
J Clin Hypertens (Greenwich)
. 2022 Jul;
24(8):1035-1043.
PMID: 35791888
White-coat hypertension (WCH) is associated with increased cardiovascular risks. To investigate the relationship between WCH and left ventricular hypertrophy (LVH), the authors recruited 706 participants who underwent anthropometric measurements, blood...
10.
Dong M, Li C, Yang G, Gou Q, Zhao Q, Liu Y, et al.
Ann Transl Med
. 2022 May;
10(7):412.
PMID: 35530932
Background: Coronary pressure-derived fractional flow reverse (FFR) is the standard of the functional assessment of lesion severity. In spite of its strengths in determining ischemia-related coronary stenosis, the invasive operation...